Skip to main content
. 2022 Jul 17;14(14):3472. doi: 10.3390/cancers14143472

Table 1.

Main clinical characteristics of patients harboring BRAF alterations detected through the analysis of the cBioPortal.

Clinical Characteristics Total
(n = 236)
Class 1
(n = 45)
Class 2
(n = 48)
Class 3
(n = 46)
Undefined Class
(n = 97)
p Value
Age, Mean (SD) 66.0 (9.4) 66.6 (10.6) 68.5 (9.6) 65.7 (8.8) 64.8 (8.9) 0.243
Sex, n (%)
Female 118 (51.5) 30 (68.2) 22 (47.8) 27 (58.7) 39 (41.9) 0.023
Male 111 (48.5) 14 (31.8) 24 (52.2) 19 (41.3) 54 (58.1)
Histology, n (%)
Adenocarcinoma 205 (86.9) 45 (100.0) 43 (89.6) 41 (89.1) 76 (78.4) 0.005
Squamous 23 (9.7) 0 (0) 2 (4.2) 3 (6.5) 18 (18.6)
Non-Small Cell Lung Cancer NOS 8 (3.4) 0 (0) 3 (6.2) 2 (4.3) 3 (3.1)
Geographical origin, n (%)
Caucasian 65 (73.9) 5 (45.5) 13 (65.0) 12 (100.0) 35 (77.8) 0.059
Asian 17 (19.3) 5 (45.5) 6 (30.0) 0 (0) 6 (13.3)
African 6 (6.8) 1 (9.1) 1 (5.0) 0 (0) 4 (8.9)
Smoking habit, n (%)
Yes 146 (83.4) 21 (56.8) 31 (93.9) 36 (92.3) 58 (87.9) <0.001
No 29 (16.6) 16 (43.2) 2 (6.1) 3 (7.7) 8 (12.1)

NOS: not otherwise specified.